REGULATOR AND PHARMACEUTICAL COMPOSITION ENCOMPASSING THE REGULATOR

貢獻的翻譯標題: 調控物及含有該調控物之醫藥組合物

Nan-Haw Chow (Inventor), Hsiao-Sheng Liu (Inventor), Wen-Tsan Chang (Inventor)

研究成果: Patent

摘要

The present disclosure is directed to a regulator, a pharmaceutical composition encompassing the regulator and the application thereof The regulator modulates the expression integrins and/or EMP2, and is employed for treating integrins-associated and/or EMP2-associated diseases.
原文English
專利號9180139
出版狀態Published - 2014 二月 20

指紋

Integrins
Disclosure
Pharmaceutical Preparations

引用此文

@misc{52e122aa294c4519be5a9c8630c5e169,
title = "REGULATOR AND PHARMACEUTICAL COMPOSITION ENCOMPASSING THE REGULATOR",
abstract = "The present disclosure is directed to a regulator, a pharmaceutical composition encompassing the regulator and the application thereof The regulator modulates the expression integrins and/or EMP2, and is employed for treating integrins-associated and/or EMP2-associated diseases.",
author = "Nan-Haw Chow and Hsiao-Sheng Liu and Wen-Tsan Chang",
year = "2014",
month = "2",
day = "20",
language = "English",
type = "Patent",
note = "9180139",

}

TY - PAT

T1 - REGULATOR AND PHARMACEUTICAL COMPOSITION ENCOMPASSING THE REGULATOR

AU - Chow, Nan-Haw

AU - Liu, Hsiao-Sheng

AU - Chang, Wen-Tsan

PY - 2014/2/20

Y1 - 2014/2/20

N2 - The present disclosure is directed to a regulator, a pharmaceutical composition encompassing the regulator and the application thereof The regulator modulates the expression integrins and/or EMP2, and is employed for treating integrins-associated and/or EMP2-associated diseases.

AB - The present disclosure is directed to a regulator, a pharmaceutical composition encompassing the regulator and the application thereof The regulator modulates the expression integrins and/or EMP2, and is employed for treating integrins-associated and/or EMP2-associated diseases.

M3 - Patent

M1 - 9180139

ER -